Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (895K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Das, A.
Right arrow Articles by Majumder, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Das, A.
Right arrow Articles by Majumder, H. K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2002, Vol. 30, No. 3 794-802
© 2002 Oxford University Press

An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani

Aditi Das, Chhabinath Mandal1, Arindam Dasgupta, Tanushri Sengupta and Hemanta K. Majumder*

Molecular Parasitology Laboratory and 1Drug Design, Development and Molecular Modelling, Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Calcutta 700032, India

DNA topoisomerases are ubiquitous enzymes that govern the topological interconversions of DNA thereby playing a key role in many aspects of nucleic acid metabolism. Recently determined crystal structures of topoisomerase fragments, representing nearly all the known subclasses, have been solved. The type IB enzymes are structurally distinct from other known topoisomerases but are similar to a class of enzymes referred to as tyrosine recombinases. A putative topoisomerase I open reading frame from the kinetoplastid Leishmania donovani was reported which shared a substantial degree of homology with type IB topoisomerases but having a variable C-terminus. Here we present a molecular model of the above parasite gene product, using the human topoisomerase I crystal structure in complex with a 22 bp oligonucleotide as a template. Our studies indicate that the overall structure of the parasite protein is similar to the human enzyme; however, major differences occur in the C-terminal loop, which harbors a serine in place of the usual catalytic tyrosine. Most other structural themes common to type IB topoisomerases, including secondary structural folds, hinged clamps that open and close to bind DNA, nucleophilic attack on the scissile DNA strand and formation of a ternary complex with the topoisomerase I inhibitor camptothecin could be visualized in our homology model. The validity of serine acting as the nucleophile in the case of the parasite protein model was corroborated with our biochemical mapping of the active site with topoisomerase I enzyme purified from L.donovani promastigotes.

* To whom correspondence should be addressed. Tel: +91 33 473 6793; Fax: +91 33 473 5197; Email: hkmajumder{at}iicb.res.in The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
J.-F. Marquis, I. Hardy, and M. Olivier
Topoisomerase I Amino Acid Substitutions, Gly185Arg and Asp325Glu, Confer Camptothecin Resistance in Leishmania donovani
Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1441 - 1446.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Villa, A. R. Otero Marcos, R. M. Reguera, R. Balana-Fouce, C. Garcia-Estrada, Y. Perez-Pertejo, B. L. Tekwani, P. J. Myler, K. D. Stuart, M.-A. Bjornsti, et al.
A Novel Active DNA Topoisomerase I in Leishmania donovani
J. Biol. Chem., January 31, 2003; 278(6): 3521 - 3526.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.